NORML Remembers Dr. Mark Kleiman

NORML regrets the passing of Prof. Mark A. R. Kleiman, an academic expert on cannabis policy who often shared and debated his well informed views on marijuana policy reform with those of us who were committed to advocating for a policy of adult use legalization.

Canopy breaks ground on NY hemp industrial park

One of the largest cannabis companies in the world made a significant move into the U.S. hemp industry Monday by breaking ground on a new industrial park for hemp processing in New York. Canadian cannabis pioneer Canopy Growth Corp., based in Smith Falls, Ontario, unveiled plans for its new $150 million Hemp Industrial Park in […]

SOL Global increases ownership stake in HeavenlyRx

Cannabis investment company SOL Global Investments purchased additional common shares to raise its ownership in its CBD-focused wellness subsidiary HeavenlyRx to 44.53%. As part of a larger private offering, the Toronto-based international investment company announced Monday it spent an additional $18.1 million (23.9 million Canadian dollars) on HeavenlyRx. The announcement comes just weeks after Sol […]

Curaleaf scrubs website for medical claims following FDA warning

After federal regulators warned cannabis giant Curaleaf last week against making unsubstantiated medical claims for its CBD products, the company has taken action. The Massachusetts cannabis company removed its blog and deleted social media posts and articles on its website saying its products can be used to treat medical conditions such as cancer, Alzheimer’s disease, chronic […]

1 182 183 184 185 186 197
Right Menu Icon